Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Sebastiani

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Current Obesity Reports|August 7, 2024
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare ProfessionalsKahei Au, Ming-Hua Zheng, Wei-Jei Lee, et al.
The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.
JHEP Reports : Innovation in Hepatology|August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver diseaseGrazia Pennisi, Marco Enea, Mauro Viganò, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.
Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
Cell Reports. Medicine|May 22, 2026
An international multidisciplinary consensus statement on laparoscopic liver biopsySi-Yi Lei, Yu Han, Don C Rockey, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Current Obesity Reports|August 7, 2024
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare ProfessionalsKahei Au, Ming-Hua Zheng, Wei-Jei Lee, et al.
The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.
JHEP Reports : Innovation in Hepatology|August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver diseaseGrazia Pennisi, Marco Enea, Mauro Viganò, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.
Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
Cell Reports. Medicine|May 22, 2026
An international multidisciplinary consensus statement on laparoscopic liver biopsySi-Yi Lei, Yu Han, Don C Rockey, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Pageof 21